Statin Modulation of Human T-Cell Proliferation, IL-1 and IL-17 Production, and IFN- T Cell Expression: Synergy with Conventional Immunosuppressive Agents
Open accessAbstract
HMG-CoA reductase inhibitors (statins) have been demonstrated to be immunomodulatory for human immune-mediated disease and in experimental models. The aim of this study was to compare statin-mediated immunosuppressive effects on human T-cell responses in vitro with those of conventional immunosuppressives (dexamethasone, cyclosporin A (CsA), mycophenolate, and rapamycin). Statins (atorvastatin, lovastatin, and simvastatin) were investigated for their modulatory effects on human PBMC viability, cytokine profiles, and T-cell proliferation. At concentrations that inhibited anti-CD3/28-stimulated T-cell proliferation (), simvastatin significantly decreased intracellular CD4+T-cell expression of IFN- () to levels similar to those induced by conventional immunosuppressives. Atorvastatin and lovastatin also decreased IFN- expression, although to a lesser degree (). All three statins reduced levels of IL-17 production (). However, in response to anti-CD3/28 stimulation, simvastatin significantly upregulated IL-1 production (). The profile of cytokines produced in response to anti-CD3/28 stimulation was similar when both atorvastatin and dexamethasone were added as compared with dexamethasone alone, suggesting that atorvastatin can synergise with dexamethasone with respect to immunomodulation of cytokines. This data supports the hypothesis of selective statin-mediated immunomodulatory effects on human immune cells.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Atorvastatin decreases Th17 responses in various models and in humans.
“Atorvastatin, among other statins, was also shown to decrease Th17 responses in various models and in humans (Aktunc et al., 2011; Li et al., 2011; Jameel et al., 2013; Lappegard et al., 2013).”
From Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice (2015) · cites this paper as Jameel et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,369 · see citing works
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727 · see citing works
Activators and Target Genes of Rel/NF-кB Transcription Factors
Loop, T., & Pahl, H. L. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,179 · see citing works
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383 · see citing works
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,094 · see citing works
Weitz‐Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J. A., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041 · see citing works
Sirolimus: its discovery, biological properties, and mechanism of action
Sehgal, S. N. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00211-2 · Cited by 784 · see citing works
Statin therapy and autoimmune disease: from protein prenylation to immunomodulation
Greenwood, J., Steinman, L., & Zamvil, S. S. (2006) · Nature reviews. Immunology · doi:10.1038/nri1839 · Cited by 696 · see citing works
Oral simvastatin treatment in relapsing-remitting multiple sclerosis
Vollmer, T. R., Key, L., Durkalski, V., Tyor, W. R., Corboy, J. R., Markovic‐Plese, S., Preiningerova, J. L., Rizzo, M., & Singh, I. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16205-3 · Cited by 471 · see citing works
A novel anti-inflammatory role for simvastatin in inflammatory arthritis.
Leung, B. P., Sattar, N., Crilly, A., Prach, M., McCarey, D. W., Payne, H., Madhok, R., Campbell, C., Gracie, J. A., Liew, F. Y., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1524 · Cited by 434 · see citing works
Weber, C., Erl, W., Weber, K. S. C., & Weber, P. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00324-0 · Cited by 409 · see citing works
Pasceri, V., & Yeh, E. T. H. (1999) · Circulation · doi:10.1161/01.cir.100.21.2124 · Cited by 381 · see citing works
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.
Koshy, M., Berger, D., & Crow, M. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118855 · Cited by 363 · see citing works
Statins as anti-inflammatory agents
Weitz‐Schmidt, G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02077-1 · Cited by 354 · see citing works
Anti-inflammatory and immunomodulatory effects of statins
Blanco‐Colio, L. M., Tuñón, J., Martı́n-Ventura, J. L., & Egido, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00744.x · Cited by 343 · see citing works
Aktaş, O., Waiczies, S., Тихоновна, С. А., Dörr, J. R., Seeger, B., Prozorovski, T., Sallach, S., Endres, M., Brocke, S., Nitsch, R., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021425 · Cited by 282 · see citing works
Inflammation: A pivotal link between autoimmune diseases and atherosclerosis
Abou‐Raya, A., & Abou‐Raya, S. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.12.006 · Cited by 264 · see citing works
Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery
Chello, M., Patti, G., Candura, D., Mastrobuoni, S., Sciascio, G. D., Agrò, F. E., Carassiti, M., & Covino, E. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000201407.89977.ea · Cited by 213 · see citing works
What is a relevant statin concentration in cell experiments claiming pleiotropic effects?
Björkhem‐Bergman, L., Lindh, J. D., & Bergman, P. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03907.x · Cited by 207 · see citing works
Zhang, X., Jin, J., Peng, X., Ramgolam, V. S., & Markovic‐Plese, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6988 · Cited by 203 · see citing works
Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients
Ascer, E., Bertolami, M. C., Venturinelli, M. L., Buccheri, V., Souza, J. A., Nicolau, J. C., Ramires, J. A. F., & Junior, C. V. S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.003 · Cited by 194 · see citing works
Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia
Musiał, J., Undas, A., Gajewski, P., Jankowski, M., Sydor, W., & Szczeklik, A. (2001) · International Journal of Cardiology · doi:10.1016/s0167-5273(00)00439-3 · Cited by 175 · see citing works
Niwa, S., Totsuka, T., & Hayashi, S. (1996) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(96)00068-9 · Cited by 161 · see citing works
Nath, N., Giri, S., Prasad, R. C., Singh, A. K., & Singh, I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1273 · Cited by 158 · see citing works
Brinkmann, V., & Kristofic, C. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.7.3322 · Cited by 152 · see citing works
Jury, E. C., Isenberg, D. A., Mauri, C., & Ehrenstein, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7416 · Cited by 138 · see citing works
Lewis, T. V., Dart, A. M., & Chin-Dusting, J. P. F. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00667-6 · Cited by 128 · see citing works
Effects of simvastatin and atorvastatin on inflammation markers in plasma
Wiklund, O., Hultén, L. M., Hurt‐Camejo, E., & Oscarsson, J. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00966.x · Cited by 117 · see citing works
Bu, D.-X., Tarrio, M. L., Grabie, N., Zhang, Y., Yamazaki, H., Stavrakis, G., Maganto-García, E., Pepper-Cunningham, Z. A., Jarolı́m, P., Aikawa, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41384 · Cited by 105 · see citing works
Wæhre, T., Damås, J. K., Gullestad, L. L., Holm, A. M., Pedersen, T. R., Arnesen, K. E., Torsvik, H., Frøland, S. S., Semb, A. G., & Aukrust, P. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00263-8 · Cited by 105 · see citing works
Therapeutic potential of lovastatin in multiple sclerosis
Sena, A., Pedrosa, R., & Morais, M. G. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1070-8 · Cited by 96 · see citing works
Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures
Franchimont, D. P., Louis, E. J., Dewé, W., Martens, H., VRINDTS‐GEVAERT, Y., Groote, D. D., Bélaïche, J., & Geenen, V. G. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(97)01063-x · Cited by 95 · see citing works
Kwak, B. R., Mulhaupt, F., Veillard, N. R., & Granziano, P. (2001) · Swiss Medical Weekly · doi:10.4414/smw.2001.06144 · Cited by 94 · see citing works
Aprahamian, T. R., Bonegio, R. G. B., Rizzo, J. L., Perlman, H., Lefer, D. J., Rifkin, I. R., & Walsh, K. X. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3028 · Cited by 93 · see citing works
Immunomodulation of experimental autoimmune encephalomyelitis in the Lewis rats by Lovastatin
Stanislaus, R., Gilg, A. G., Singh, A. K., et al. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00943-6 · Cited by 73 · see citing works
Suppression of Autoimmune Retinal Disease by Lovastatin Does Not Require Th2 Cytokine Induction
Gegg, M. E., Harry, R. A., Hankey, D. J. R., Zambarakji, H., Pryce, G., Baker, D., Adamson, P., Calder, V. L., & Greenwood, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2327 · Cited by 69 · see citing works
Self-citationImpact of Mycophenolic Acid and Tacrolimus on Th17-Related Immune Response
Abadja, F., Atemkeng, S., Alamartine, É., et al. (2011) · Transplantation · doi:10.1097/tp.0b013e3182247b5f · Cited by 53 · see citing works
Statins for multiple sclerosis
Wang, J., Xiao, Y., Luo, M., & Luo, H. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008386.pub3 · Cited by 47 · see citing works
Moed, H. D., Stoof, T. J., BOORSMA, D. M., et al. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.02124.x · Cited by 45 · see citing works
Aktunc, E., Kayhan, B., Arasli, M., Gun, B. D., & Barut, F. (2011) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2011.559475 · Cited by 44 · see citing works
The effects of atorvastatin in experimental autoimmune uveitis
Thomas, P. B. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.050401 · Cited by 36 · see citing works
Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin
Kohno, H., Sakai, T., Saitô, S., Okano, K., & Kitahara, K. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2006.11.011 · Cited by 31 · see citing works
Statins: immunomodulators for autoimmune rheumatic disease?
Jury, E. C., & Ehrenstein, M. R. (2005) · Lupus · doi:10.1191/0961203303lu2135oa · Cited by 30 · see citing works
Zineh, I., Luo, X., Welder, G. J., DeBella, A. E., Wessel, T. R., Arant, C. B., Schofield, R. S., & Chegini, N. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.3.333 · Cited by 30 · see citing works
Hill, T., GALATOWICZ, G. E., Akerele, T., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02669.x · Cited by 25 · see citing works
Self-citationErikstrup, C., Ullum, H., & Pedersen, B. K. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03042.x · Cited by 22 · see citing works
Statins as modulators of colon cancer cells induced cytokine secretion by human PBMC
Bergman, M., Salman, H., Djaldetti, M., & Bessler, H. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.03.002 · Cited by 20 · see citing works
Härtel, C., Hammers, H.-J., Schlenke, P., et al. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/107999003321455480 · Cited by 12 · see citing works
Nie, C., Yang, D., Liu, G., Dong, D.-L., Ma, Z., Fu, H., Zhao, Z., & Sun, Z. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.11.022 · Cited by 11 · see citing works
Atorvastatin Prevented and Reversed Dexamethasone-Induced Hypertension in the Rat
Mondo, C. K., Yang, W., Su, J.-Z., et al. (2006) · Clinical and Experimental Hypertension · doi:10.1080/10641960600798713 · Cited by 11 · see citing works
Statins for multiple sclerosis
Wang, J., Xiao, Y., Luo, M., Zhang, X., & Luo, H. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008386.pub2 · Cited by 5 · see citing works
Huang, W. Y., Cai, Z., Sun, W. J., et al. (2004) · PubMed · Cited by 2 · see citing works
Ch, L., Xw, L., Li, H., et al. (2001) · PubMed · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice
Rahal, E. A., Constantin, W. N., Zeidan, N., & Abdelnoor, A. M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01474 · Cited by 14 · see citing works
- Authors
- Jameel, A., Ooi, K. G.-J., Jeffs, N. R., Galatowicz, G., Lightman, S. L., & Calder, V. L.
- Affiliations
- University College London (GB)
- Moorfields Eye Hospital (GB)
- Corresponding author
- Calder, Virginia L.
- ORCID
- Venue
- International Journal of Inflammation
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-11
- ISSN
- 2042-0099 (ISSN-L)
- 2090-8040
- PMC
- PMC3789401
- OpenAlex
- W2006205937
- Cited by
- 43
- References
- 53
- Citations by year
- 2026: 1 · 2025: 7 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 1 · 2017: 8 · 2016: 2 · 2015: 4 · 2014: 1
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- statins, immunomodulation, T cell proliferation, interferon-gamma, IL-17, IL-1β, atorvastatin, lovastatin, simvastatin, dexamethasone, cyclosporine, mycophenolate, rapamycin, CD4+ T cells, cytokine production
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
